Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction.
acute coronary syndrome
coronary heart disease
prognosis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Jan 2021
07 Jan 2021
Historique:
received:
07
12
2020
revised:
23
12
2020
accepted:
31
12
2020
entrez:
12
1
2021
pubmed:
13
1
2021
medline:
13
1
2021
Statut:
epublish
Résumé
Available data comparing long-term prognosis according to the type of acute coronary syndrome (ACS) are scarce, contradictory, and outdated. Our aim was to compare short- and long-term mortality in ST-elevated (STEMI) and non-ST-elevated myocardial infarction (non-STEMI) ACS patients. Patients presenting with an inaugural ACS during the year 2006 and living in one of the three areas in France covered by the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) registry were included. A total of 1822 patients with a first ACS-1121 (61.5%) STEMI and 701 (38.5%) non-STEMI-were included in the study. At the 28-day follow-up, the mortality rates were 6.7% and 4.7% ( STEMI patients have a worse vital prognosis than non-STEMI patients within 28 days following ACS. However, at the 10-year follow-up, STEMI and non-STEMI patients have a similar vital prognosis. From the 2nd year onwards following the occurrence of a first ACS, the patients become stable coronary artery disease patients with an annual mortality rate in the 2% range, regardless of the type of ACS they initially present with.
Sections du résumé
BACKGROUND
BACKGROUND
Available data comparing long-term prognosis according to the type of acute coronary syndrome (ACS) are scarce, contradictory, and outdated. Our aim was to compare short- and long-term mortality in ST-elevated (STEMI) and non-ST-elevated myocardial infarction (non-STEMI) ACS patients.
METHODS
METHODS
Patients presenting with an inaugural ACS during the year 2006 and living in one of the three areas in France covered by the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) registry were included.
RESULTS
RESULTS
A total of 1822 patients with a first ACS-1121 (61.5%) STEMI and 701 (38.5%) non-STEMI-were included in the study. At the 28-day follow-up, the mortality rates were 6.7% and 4.7% (
CONCLUSION
CONCLUSIONS
STEMI patients have a worse vital prognosis than non-STEMI patients within 28 days following ACS. However, at the 10-year follow-up, STEMI and non-STEMI patients have a similar vital prognosis. From the 2nd year onwards following the occurrence of a first ACS, the patients become stable coronary artery disease patients with an annual mortality rate in the 2% range, regardless of the type of ACS they initially present with.
Identifiants
pubmed: 33430516
pii: jcm10020180
doi: 10.3390/jcm10020180
pmc: PMC7826729
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur Heart J. 2005 Jan;26(1):18-26
pubmed: 15615795
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Eur Heart J. 2020 Aug 29;:
pubmed: 32860058
Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1125
pubmed: 26675199
Int J Cardiol. 2011 Oct 6;152(1):70-7
pubmed: 20684999
Eur J Heart Fail. 2020 Apr;22(4):664-672
pubmed: 32078218
Am J Cardiol. 2009 Aug 1;104(3):333-7
pubmed: 19616663
JACC Cardiovasc Interv. 2019 Sep 23;12(18):1825-1836
pubmed: 31537282
Lancet. 1999 May 8;353(9164):1547-57
pubmed: 10334252
Am Heart J. 2006 May;151(5):1065-71
pubmed: 16644337
Am J Cardiol. 1995 Jun 15;75(17):1202-5
pubmed: 7778539
Circulation. 2010 Jun 22;121(24):2681-91
pubmed: 20566966
Circulation. 2009 Jun 23;119(24):3110-7
pubmed: 19506116
Clin Cardiol. 2017 Dec;40(12):1256-1263
pubmed: 29243857
Int J Clin Exp Med. 2014 Dec 15;7(12):5588-92
pubmed: 25664077
EuroIntervention. 2016 Jun 20;12(3):303-11
pubmed: 26485732
Eur Heart J. 2007 Jun;28(12):1409-17
pubmed: 17412730
N Engl J Med. 2013 May 23;368(21):2004-13
pubmed: 23697515
N Engl J Med. 2007 Mar 8;356(10):1009-19
pubmed: 17296822
Int J Cardiol. 2013 Nov 15;169(4):254-61
pubmed: 24071385
N Engl J Med. 2017 May 25;376(21):2053-2064
pubmed: 28538121
Heart. 2001 Oct;86(4):391-6
pubmed: 11559675
Am J Cardiol. 2011 Oct 15;108(8):1061-7
pubmed: 21791326
Am Heart J. 2019 Aug;214:97-106
pubmed: 31181374